Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
It was originally developed for patients with type 2 diabetes
But you called it something else, so Id like you to talk about that, but also tell us whats out there
The study found that the reduction in postprandial hyperglycaemia with acarbose therapy was not only associated with a 36% reduction in newly diagnosed diabetes, but also with a 34% relative risk reduction in the incidence of new cases of hypertension ( P = 0.006) and a 49% relative risk reduction in the development of cardiovascular events ( P = 0.03) over a mean follow-up of 3.3 years (Table 1) [20]
Signs of true plateau: Youve been on Zepbound for a while, and the scale hasnt moved for several weeks or more, even though youre still taking your medication as prescribed, eating well, and staying active
